Developing clinical diagnostic testing to transform rheumatoid arthritis care.
Rheumasense is actively developing its groundbreaking diagnostic technology for use in clinical studies, paving the way for FDA submission and future commercialization. To accelerate this progress, we are initiating a seed funding round, inviting investors to join us in transforming rheumatoid arthritis care. With strong partnerships and a clear vision, we are poised to deliver innovative solutions that will reshape chronic disease management.